The impact of implementing an allergic rhinitis clinical management pathway (AR-CMaP) in the community pharmacy

Rachel House, Vicky Kritikos, Biljana Cvetkovski, Janet Rimmer, Kwok Yan, Lynn Cheong, Jean Bousquet, Olga Lourenco, Sinthia Bosnic-Anticevich

Research output: Contribution to journalArticlepeer-review

Abstract

Background
The Allergic Rhinitis Clinical Management Pathway (AR-CMaP) was developed to overcome the challenge of implementing current AR guidelines in the Australian community pharmacy practice and support pharmacists in optimally managing patients' AR.

Objective(s)
To evaluate the impact of AR-CMaP on patients' behaviour and pharmacists' needs in managing AR in the pharmacy.

Methods
This study used a cross-sectional, pre-post study design in which the primary outcome was the appropriateness of medications purchased from community pharmacies in Australia. Patient data were collected before and after the implementation of AR-CMaP. Pharmacist needs were recorded before and after AR-CMaP training. Data were analysed descriptively.

Results
Six pharmacies, 19 pharmacists and a total of 416 patients were included in the study; 206 pre-AR-CMaP implementation and 210 post-AR-CMaP implementation. Pre-AR-CMaP, 22.4% of patients purchased appropriate AR medication compared with 29.0% post-AR-CMaP implementation. Over half the patient cohort (52%) consulted a pharmacist pre-AR-CMaP and 37% consulted a pharmacist post-AR-CMaP implementation. Post-AR-CMaP, pharmacists reported increased awareness of barriers such as patients' lack of time, patients' perceptions about the pharmacist's role and patient choice to self-manage. Pharmacists also rated an increased desire to interact with other health care providers (HCPs) in caring for patients with AR.

Conclusions
While there was a non-statistically significant increase in the proportion of patients purchasing optimal AR medication, AR-CMaP did empower patients to self-select their own medication without further detriment. Moreover, following the implementation of AR-CMaP, pharmacists developed a greater awareness of their role in AR management, exemplified by their increased desire to be actively involved in AR management and increased interaction with other HCPs. Future research needs to explore more effective tools to support pharmacists' clinical decision-making and target patients' self-selection of AR medications. This study highlights that there is an ingrained self-reliance of AR decision-making that has become a habit for people living with AR.
Original languageEnglish
Article number100340
Pages (from-to)1-21
Number of pages21
JournalExploratory Research in Clinical and Social Pharmacy
Volume12
Early online date5 Oct 2023
DOIs
Publication statusPublished - Dec 2023

Fingerprint

Dive into the research topics of 'The impact of implementing an allergic rhinitis clinical management pathway (AR-CMaP) in the community pharmacy'. Together they form a unique fingerprint.

Cite this